Black Health
SSRI Depression Anxiety disorders OCD PTSD Vasomotor symptoms of menopause (Brisdelle)

Paroxetine (Paxil, Pexeva, Brisdelle) and Black patients

Brand names: Paxil, Pexeva, Brisdelle

Last reviewed: Sources checked:

What Paroxetine does

Paroxetine is one of the oldest SSRIs and remains widely prescribed, though it has largely been displaced by sertraline and escitalopram as first-line. It has the shortest half-life of the common SSRIs, the most anticholinergic side effects, and the most severe discontinuation syndrome.

What the evidence says for Black patients

Paroxetine is a potent CYP2D6 inhibitor and is itself metabolized by CYP2D6. This creates pharmacokinetic complexity that is not specifically race-differential but does interact with codeine (converted to morphine by CYP2D6) and tamoxifen (converted to endoxifen by CYP2D6) — both drugs relevant to Black patient populations (codeine analgesia, tamoxifen for ER+ breast cancer). Co-prescription of paroxetine with tamoxifen should be avoided.

Trial evidence in Black participants mirrors other SSRIs — small or no efficacy difference after adjusting for socioeconomic covariates; continuation is the dominant driver of outcome. Paroxetine's side-effect and discontinuation profile makes it a less favorable first choice.

In pregnancy, paroxetine carries a specific concern: the 2005 GSK epidemiology data and subsequent studies suggest a modestly increased risk of cardiac malformations with first-trimester exposure (Bar-Oz et al., Clin Ther 2007;29:918–26). FDA changed paroxetine to Pregnancy Category D. Because Black women face higher baseline rates of adverse pregnancy outcomes, avoiding paroxetine when pregnancy is possible is a reasonable position.

Common alternatives

Sertraline (often better tolerated, milder discontinuation), escitalopram, fluoxetine (preferred SSRI in pregnancy when one is necessary).

Side effects

  • Sexual dysfunction (highest rate among SSRIs)
  • Weight gain
  • Sedation, dry mouth, constipation (anticholinergic)
  • Severe discontinuation syndrome — 'brain zaps', dizziness, flu-like symptoms; must taper
  • Boxed warning — suicidality in young adults
  • Teratogenicity concern

Factors that affect adherence

Because of discontinuation severity, never stop paroxetine abruptly. Transition to a longer-half-life SSRI like fluoxetine can smooth the switch if discontinuation is planned. Generic paroxetine is inexpensive.

Questions to ask your doctor

Bring this list to your next appointment.

  • Given the discontinuation syndrome, is paroxetine still the right choice for me, or should we consider a different SSRI?
  • If I might become pregnant, what are the alternatives?
  • If I'm on tamoxifen, is a different SSRI safer?
  • How do we safely taper off if we switch?

References

  1. Bar-Oz B, Einarson T, Einarson A, et al. Paroxetine and congenital malformations: meta-analysis and consideration of potential confounding factors. Clin Ther. 2007;29:918–926.
  2. Hicks JK, Bishop JR, Sangkuhl K, et al. CPIC guideline for CYP2D6 and CYP2C19 and SSRI dosing. Clin Pharmacol Ther. 2015;98:127–134.
  3. U.S. Food and Drug Administration. Paxil (paroxetine hydrochloride) label. https://www.accessdata.fda.gov/drugsatfda_docs/label/2012/020031s067,020710s031.pdf

Medical disclaimer

This page is patient education, not prescribing guidance. It summarizes the published evidence about how this medication has been studied in Black patients — it is not a substitute for the judgment of your personal clinician. Never start, stop, or change a prescription based on something you read here. If you have questions about your medication, call your prescriber or pharmacist. For emergencies, call 911.

Read our editorial standards for how we source, review, and update these pages.